GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival

Background and Objective: Liver cancer is a malignancy with a poor prognosis. G protein signaling modulator 2 is mainly related to cell division and cell cycle regulation. In this review, the relationship between G protein signaling modulator 2 and clinical characteristics of patients with liver can...

Full description

Bibliographic Details
Main Authors:	Dingquan Yang PhD, Fujian Ji MD, Yanqing Li PhD, Yan Jiao PhD, Xuedong Fang MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-08-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/1533033820945817

Similar Items

Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer
by: Dingquan Yang, et al.
Published: (2020-01-01)

TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
by: Jing Sun PhD, et al.
Published: (2020-11-01)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas
by: Ming Wang, et al.
Published: (2021-11-01)

Preoperative Biliary Drainage Does Not Independently Reduce Survival After Pancreaticoduodenectomy Among Patients With Pancreatic Ductal Adenocarcinoma
by: Karin Johansen, MD, et al.
Published: (2021-09-01)

Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival
by: Na Dai MD, et al.
Published: (2021-11-01)

Biomarkers of Platelet Activation and Their Prognostic Value in Patients With Sepsis-Associated Disseminated Intravascular Coagulopathy
by: Gracelene Wegrzyn MD, et al.
Published: (2021-02-01)

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
by: Christopher J. Mowry, MD, et al.
Published: (2021-12-01)

Impacts of Inflammation-Based Prognostic Scores on Survival in Patients With Hypopharyngeal Squamous Cell Carcinoma
by: Hiroyuki Iuchi MD, PhD, et al.
Published: (2020-12-01)

Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction
by: Leonardo P. de Carvalho, MD, PhD, et al.
Published: (2018-04-01)

Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinoma
by: Qinglin Fei, MD, et al.
Published: (2020-09-01)

Comment on “Prognostic Effect of Liver Resection in Extended Cholecystectomy for T2 Gallbladder Cancer Revisited: A Retrospective Cohort Study with Propensity-Score-Matched Analysis”
by: Kojiro Taura, MD, PhD, et al.
Published: (2023-12-01)

Klotho and Fibroblast Growth Factor 23 Are Independent of Vitamin D, and Unlike Vitamin D, Are Not Associated With Graft- and Patient Survival After Kidney Transplantation
by: Inga Strand Thorsen, MD, et al.
Published: (2023-09-01)

Screening of Prognostic Biomarkers for Stereotactic Body Radiation Therapy in Primary Liver Cancer
by: Zhenzhen Liang PhD, et al.
Published: (2022-04-01)

The ability of biomarkers to assess the severity of atopic dermatitis
by: Takeshi Nakahara, MD, PhD, et al.
Published: (2024-02-01)

Proenkephalin A as Potential Prognostic Biomarker in Acute Ischemic Stroke
by: Azadeh Shafieesabet MD, et al.
Published: (2020-07-01)

Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma
by: Mengnan Zhao PhD, et al.
Published: (2022-07-01)

Serving as a Temporary Pathology Chair: “Boon” or “Boondoggle”?
by: David N. Bailey MD, et al.
Published: (2019-09-01)

Prognostic Factors for Survival in Multiple Primary Lung Adenocarcinomas: A Retrospective Analysis of 283 Patients
by: Yuting Zheng MD, et al.
Published: (2023-06-01)

Hyperuricemia Is Not an Independent Predictor of Erectile Dysfunction
by: Antti T. Tuokko, MD, et al.
Published: (2021-04-01)

First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia
by: Pal Abraham, MD, et al.
Published: (2015-01-01)

The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment
by: Nina J. Wesdorp, MD, et al.
Published: (2021-12-01)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
by: Yohei Yamada, MD, PhD, et al.
Published: (2018-02-01)

PD-L1NEUT, Foxp3Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma
by: Lin Zhou PhD, et al.
Published: (2021-09-01)

Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis
by: Huy-Hoang Dang, et al.
Published: (2021-09-01)

Repair of Rotator Cuff Tear With Delamination: Independent Repairs of the Infraspinatus and Articular Capsule
by: Tomoyuki Mochizuki, M.D., Ph.D., et al.
Published: (2016-10-01)

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC
by: Akira Hamada, MD, et al.
Published: (2022-05-01)

Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy
by: Naoya Yoshida, MD, PhD, et al.
Published: (2022-06-01)

MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma
by: Matthew B. Spraker, MD, PhD, et al.
Published: (2019-04-01)

Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis
by: Zhizun Lin MD, et al.
Published: (2021-10-01)

Serve, Teach, and Lead: It’s All about Relationships
by: Carolyn Crippen, PhD
Published: (2010-08-01)

Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study
by: Sevinj Yolchuyeva, PhD, et al.
Published: (2023-12-01)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
by: Yoshihide Ueda, MD, PhD, et al.
Published: (2017-12-01)

Association of Socioeconomic Disparities With Nasopharyngeal Carcinoma Survival in an Endemic Area, China
by: Dong-Fang Meng MD, PhD, et al.
Published: (2023-07-01)

Risk Factors Affecting Decreased Libido Among Middle-Aged to Elderly Men; Nocturnal Voiding is an Independent Risk Factor of Decreased Libido
by: Kazuyoshi Shigehara, MD, PhD, et al.
Published: (2021-10-01)

Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies
by: Yasue Kimura, MD, PhD, et al.
Published: (2023-12-01)

Prediction of hospital mortality after colorectal perforation surgery from inflammation-based prognostic scores
by: Kensuke Kudou, PhD, MD, et al.
Published: (2022-04-01)

Response to: “Comment on: Prognostic Effect of Liver Resection in Extended Cholecystectomy for T2 Gallbladder Cancer Revisited: A Retrospective Cohort Study with Propensity-Score-Matched Analysis”
by: Yeshong Park, MD, et al.
Published: (2023-12-01)

Hydatid cysts of the liver with concomitant massive peritoneal hydatidosis: a case report
by: Gjorgji Trajkovski, MD, PhD, et al.
Published: (2022-07-01)

Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
by: Liping Zhuang MD, PhD, et al.
Published: (2020-11-01)

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing
by: Takamasa Koga, MD, PhD, et al.
Published: (2023-09-01)